Healthcare

Novo Nordisk shares, trading near 33 euros, reflect a market grappling with the pharmaceutical giant's dual narrative. While the company...

Investors in Siemens Healthineers are bracing for a pivotal quarterly report, seeking signs that the German medical technology giant can...

The appointment of a Silicon Valley artificial intelligence expert as its new technology chief underscores Siemens Healthineers' ambitious digital health...

ImmunityBio is navigating a stark divide. While its commercial engine, driven by the cancer drug Anktiva, is firing on all...

The stock of telehealth provider Hims & Hers has been under significant pressure, trading roughly 40 percent below its level...

Positive clinical results for a late-stage cancer drug candidate have strengthened BioNTech's strategic pivot away from its pandemic-era business. The...

NurExone Biologic has taken a significant step in its US expansion strategy by forming a new alliance. The company's subsidiary,...

Hydreight Technologies is accelerating the growth of its digital health platform through a dual focus on technological advancement and strategic...

Market confidence in BioNTech is being tested as analysts from prominent firms revise their outlooks downward. Leerink Partners has taken...

Medical technology giant Abbott Laboratories has made a decisive strategic pivot, solidifying its position in the high-growth field of precision...